A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01

NCT05570422 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Cervical Cancer

Interventions

DRUG: KRC-01
RADIATION: External Beam Radiation Therapy
DRUG: cisplatin
RADIATION: brachytherapy

Sponsor

Kortuc, Inc.